These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 27478938)

  • 1. Emerging concepts of epigenetic dysregulation in hematological malignancies.
    Ntziachristos P; Abdel-Wahab O; Aifantis I
    Nat Immunol; 2016 Sep; 17(9):1016-24. PubMed ID: 27478938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.
    Qiu Y; Xu M; Huang S
    Blood; 2021 Dec; 138(23):2327-2336. PubMed ID: 34482397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics of hematopoiesis and hematological malignancies.
    Hu D; Shilatifard A
    Genes Dev; 2016 Sep; 30(18):2021-2041. PubMed ID: 27798847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs during normal and malignant hematopoiesis.
    Alvarez-Dominguez JR; Hu W; Gromatzky AA; Lodish HF
    Int J Hematol; 2014; 99(5):531-41. PubMed ID: 24609766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of long non-coding RNAs in normal and malignant hematopoiesis.
    Wei P; Han B; Chen Y
    Sci China Life Sci; 2013 Oct; 56(10):867-75. PubMed ID: 24030284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of normal and malignant hematopoiesis.
    Rice KL; Hormaeche I; Licht JD
    Oncogene; 2007 Oct; 26(47):6697-714. PubMed ID: 17934479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs in normal and malignant hematopoiesis.
    Nobili L; Lionetti M; Neri A
    Oncotarget; 2016 Aug; 7(31):50666-50681. PubMed ID: 27177333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin RNA Immunoprecipitation (ChRIP).
    Mondal T; Subhash S; Kanduri C
    Methods Mol Biol; 2018; 1689():65-76. PubMed ID: 29027165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcription by long noncoding RNAs.
    Bonasio R; Shiekhattar R
    Annu Rev Genet; 2014; 48():433-55. PubMed ID: 25251851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs in haematological malignancies.
    Garitano-Trojaola A; Agirre X; Prósper F; Fortes P
    Int J Mol Sci; 2013 Jul; 14(8):15386-422. PubMed ID: 23887658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs: emerging players in gene regulation and disease pathogenesis.
    Kazemzadeh M; Safaralizadeh R; Orang AV
    J Genet; 2015 Dec; 94(4):771-84. PubMed ID: 26690535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer.
    Rovirosa L; Ramos-Morales A; Javierre BM
    Front Immunol; 2020; 11():592087. PubMed ID: 33117405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear lncRNAs as epigenetic regulators-beyond skepticism.
    Nakagawa S; Kageyama Y
    Biochim Biophys Acta; 2014 Mar; 1839(3):215-22. PubMed ID: 24200874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of human non-coding RNA gene transcription.
    Morselli M; Dieci G
    Biochem Soc Trans; 2022 Apr; 50(2):723-736. PubMed ID: 35285478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis.
    Alvarez-Dominguez JR; Lodish HF
    Blood; 2017 Nov; 130(18):1965-1975. PubMed ID: 28928124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chromatin modifiers in normal and malignant hematopoiesis.
    Butler JS; Dent SY
    Blood; 2013 Apr; 121(16):3076-84. PubMed ID: 23287864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
    Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
    Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
    Zhao A; Zhou H; Yang J; Li M; Niu T
    Signal Transduct Target Ther; 2023 Feb; 8(1):71. PubMed ID: 36797244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of long noncoding RNAs as transcriptional regulators in cancer.
    Huang Y; Guo Q; Ding XP; Wang X
    RNA Biol; 2020 Nov; 17(11):1680-1692. PubMed ID: 31888402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.